Human parvovirus B19 as a causative agent for rheumatoid arthritis.
Ofuji S, Yamamoto O: Acute generalized exanthematous pustulosis associated with a
human parvovirus B19 infection.
Human parvovirus B19 infection resembling systemic lupus erythematosus.
Persistence of
human parvovirus B19 in human tissues.
Detection of
human parvovirus B19 DNA by using the polymerase chain reaction.
Human parvovirus PARV4 DNA in tissues from adult individuals: a comparison with
human parvovirus B19 (B19V).
human parvovirus B19, and adeno-associated viruses (6-8).
These intellectual properties include technology described in European patent number 0491824 issued to scientists at the University of Leiden in October 1995 titled,
Human Parvovirus B19 Proteins and Virus-Like Particles, Their Production and Their Use in Diagnostic Assays and Vaccines.
for the development of a diagnostic test kit for
human parvovirus B19.
Biological and immunological relations of
human parvovirus B19 genotypes 1-3.
Molecular analysis of the viral prototype genome (5,268 nt) identified 2 large, nonoverlapping open reading frames (ORFs) and showed limited homology with
human parvovirus B19 (<30% aa similarity).
The VP2 gene of
human parvovirus B19 (NC_000883) was chosen as outgroup to root this tree (Figure 2).
